Category: IPO/FPO ANALYSIS

  • Alkem Labs IPO

    Dear Reader, The IPO season in India continues with another bunch of offerings planned in December 2015. We have created a new IPO report on Alkem Labs. It is the first large pharma company IPO in over 10 years. Its got a lot going for it. At the same time, the criticism can be on the…

  • IPO Updates, CCD and IndiGo

    Dear Investor, Find here our IPO report updates: Café Coffee Day IPO UPDATE  Here is a short listing day report on the Coffee Day IPO. On 10th Oct, we had rated the IPO as an Average offering. See entire report: Café Coffee Day IPO – Very Hot Coffee  The IPO received lukewarm response with a 1.8 times…

  • Last day for IndiGo IPO

    Source: IndiGo IPO – Flying High, Wide and Handsome All, A quick reminder that today is the last day to apply to the Indigo IPO. FYI ……. to readers, our report has also been published on Investing.com website – link is http://in.investing.com/analysis/indigoipo-flying-high-wide-and-handsome, and on ValueNotes website, link is http://www.indianotes.com/Analysis/IndiGo-IPO-Flying-High-Wide-and-Handsome Happy investing Punit Jain

  • IndiGo IPO – Flying High, Wide and Handsome

    Date Oct 27th 2015 IPO Period: 27-29th Oct 2015  Price range: Rs. 700-765 Industry – Airlines. Large Cap – 27,600 crores mkt cap Advice: Good offering with medium risks. BUY with a minimum 1 year horizon Overview: IndiGo is the market leader in Indian aviation with a low cost carrier model. The 97 aircraft cover 647 flights daily to…

  • Café Coffee Day IPO – Very Hot Coffee

    Date 10th Oct 2015 Mid Cap – Rs 4,979 cr Mkt Cap Industry – Coffee QSR, conglomerate Price range: Rs. 316-328 and Period:  14-16th Oct 2015 Advice: Average offering with medium to high risks.  Summary Overview: Coffee Day Enterprises is a conglomerate into coffee, logistics, hospitality, financial services and technology parks. The “Café Coffee Day”…

  • Syngene Post IPO report

    Post IPO report dated 17th Aug 2015 Dear Investor, Here is a short post listing report on the Syngene International IPO. The IPO that was open from 27-29th July received excellent response with a 32.05 times over-subscription. While Retail was only 4.8 times oversubscribed, the QIB portion was over 51.5 times and non institutional investors (NII) category…

  • Syngene IPO: Good Pharma R&D spinoff from Biocon

    Date – 27th July 2015 Issue Price range: Rs. 240-250 and Issue Period: 27-29th July 2015 Target Market Cap Rs 5,000 crore and Industry – Pharma R&D First day – 32% subscribed Advice: Buy for 2-3 years The Syngene IPO is a first time offer from the high potential sector of pharma R&D Outsourcing. The Income, EBITDA…